PKPhilip J. Katzman

Philip J. Katzman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Philip J. Katzman has a total of 87 co-authors. Here are the top co-authors by number of shared publications:

  • Leon A. Metlay

    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA

    3 shared publications
  • Christina Sollinger

    Department of Pediatrics, Golisano Children's Hospital, University of Rochester Medical Center, Rochester, New York, USA

    2 shared publications
  • Jeffrey M. Vinocur

    Yale School of Medicine

    2 shared publications
  • Leon A Metlay

    Department of Pathology and Laboratory Medicine, Strong Memorial Hospital, University of Rochester Medical Center, Rochester, New York

    2 shared publications
  • Nisha Patel

    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, USA

    2 shared publications
  • Richard K. Miller

    Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY 14642, USA

    2 shared publications

Latest Publications

  • Open Access

    Standardized Placental Pathology Reporting: Improving Quality and Clinical Utility Recommendations From the Society for Pediatric Pathology Placental Pathology Reporting Task Force

    by Sanjita Ravishankar, Francois Cady, Chrystalle Katte Carreon, Eumenia Castro, Virginia E. Duncan, Philip J. Katzman, Drucilla J. Roberts, Karen K. Mestan, Cynthia Gyamfi-Bannerman, Heather Florescue, et al.

    Background: Placental pathology has benefited greatly from the standardization of definitions provided by the Amsterdam consensus, however the quality of placental pathology reporting continues to suffer from a lack of unified and practical reporting standards and difficulty in applying the Amsterdam definitions to general clinical practice. Methods: A multidisciplinary Placental Pathology Reporting Task Force was formed to develop a standardized placental pathology reporting template based on a combination of evidence-based literature review and consensus expert opinion, and designed to complement the Amsterdam definitions. The goal of the task force was to create a practical, succinct, clinically informative, and easily customizable template that can be adapted to varying institutional preferences. Results: The proposed standardized reporting template encompasses a wide breadth of common placental pathologic diagnoses and provides recommended diagnostic terminology, explanatory comments and practical tips, and notes to ease the application of definitions. Input from pathologists from different practice settings, obstetric providers, neonatologists, and patient advocates was integrated. Conclusions: The introduction of a standardized placental reporting template holds the potential to reform and advance placental pathology practice across the diverse range of settings in which it is currently performed. The proposed template is adaptable, allowing pathologists to include additional information beyond the recommended standard as needed/preferred. Widespread adoption of this framework will enhance the clinical utility and value of placental pathology reports by clinicians and patients, ultimately supporting more informed and appropriate management of neonates and future pregnancies.

  • Open Access

    A Reassessment of Chorionic Histiocytic Hyperplasia in Association With Other Inflammatory Lesions of the Placenta

    by Philip J. Katzman, Leon A. Metlay

    Background: Chorionic histiocytic hyperplasia (CHH) is a chronic inflammatory lesion (CIL) with a linear infiltrate of fetal histiocytes in the base of fetal or membranous chorion. We performed a retrospective study of placentas diagnosed since our last study period in order to analyze the strength of the association of CHH with other CIL. Methods: Third trimester placentas diagnosed with CHH were identified in our LIS. Comparisons of incidence of associated lesions, including chronic villitis (CV), chronic deciduitis (CD), chronic chorioamnionitis (CC), eosinophilic/T-cell chorionic vasculitis (ETCV), and maternal and fetal acute inflammatory responses, between the prior and current studies were evaluated using the chi square statistic. Results: CHH was present in 2.2% of placentas, significantly higher than 1.3% in the prior study period. A majority of CHH cases had accompanying CV (82.3%). CD was more often associated with CHH in the current study than in the prior study (49.1% vs 40.0%). Conclusions: The greater incidence of CHH in third trimester placentas diagnosed in the past 7.5 years may be due to greater recognition of the lesion by our pathologists. This study demonstrated the need for more research of CIL.


  • Triaging and Evaluation of Products of Conception in Abortions and Post-Partum Hemorrhage

    by Philip J. Katzman, Jonathan L Hecht

    The proper evaluation of abortion specimens and placentas from stillbirth and post-partum cases is important for adequate clinical care of post-abortion and post-partum patients. The following topics will be reviewed: (1) the importance of evaluation of both fetal and placental tissue in first trimester abortions to confirm an intrauterine pregnancy versus an ectopic pregnancy; (2) the clinical history associated with an abortion specimen or retained products of conception (POC) influences how the pathologist should triage the specimen; (3) the criteria for diagnosis of a molar pregnancy, which is critical for clinicians to know which patients need follow-up; (4) the utility of genetic studies for both diagnosis and appropriate follow-up of the patient; and (5) the pathologic evaluation of specimens from patients with post-partum hemorrhage for placenta accreta spectrum and subinvolution of maternal vessels.

  • Whole Lung Proteomics in Bronchopulmonary Dysplasia

    by A.M. Dylag, R. Misra, G. Bandyopadhyay, C. Poole, H. Huyck, J. Haak, J. Woo, H. Olson, G. Deutsch, P. Katzman, et al.

  • Myocardial Calcification and the Demise of an Infant With Surgically Treated Hypoplastic Left Heart Syndrome

    by Cynthia Reyes Barron, Philip J Katzman

    A term female infant with hypoplastic left heart syndrome underwent Norwood palliation including aortic and pulmonary amalgamation with arch reconstruction, atrial septectomy, and right ventricle to pulmonary artery conduit. Postoperatively, she experienced hypoxemia and lactic acidosis although echocardiogram showed adequate conduit function. She was placed on veno-arterial extracorporeal membrane oxygenation (ECMO) on postoperative day two with improvement. ECMO decannulation was attempted with subsequent cardiac arrest and ultimate failure to resuscitate, eleven days after surgery. Autopsy confirmed clinical findings and evidence of surgical intervention with a patent conduit and neo-aorta. Multiple subendocardial right ventricular dystrophic calcifications involving the outflow tract were identified grossly and histologically with foci of associated myonecrosis. Myocardial calcification may lead to abnormal heart wall motion by increasing rigidity and compromising myocyte function or compromising the conduction system. In this patient, right ventricular turbulence caused by systolic and diastolic flow patterns, including mild tricuspid regurgitation, may have played a role in inducing dystrophic calcification along with surgery and ECMO dependence. Compromised myocyte function from calcifications, right ventricular hypertrophy, lung immaturity, and persistent pulmonary hypertension were likely sources of cardiac strain leading to the patient’s demise. This case represents a previously unreported complication of hypoplastic left heart syndrome treatment.


  • Placental Chorionic Cyst Fluid Has Prothrombotic Properties and Differs From Amniotic Fluid

    by Moritz Stolla, Majed A Refaai, Grace Conley, Sherry Spinelli, Ann Casey, Hani Katerji, Hannah L McRae, Neil Blumberg, Richard Phipps, Leon A Metlay, et al.

    Introduction: Chorionic cysts of the chorion laeve, fetal chorionic plate, septum, and free membranes have been associated with placental hypoxia, but they have no clear clinical significance. Although immunohistochemistry has identified fibronectin and collagen IV in cyst fluid, the contents have yet to be fully characterized. Methods: Placental chorionic cysts (N = 10) were sampled by fluid extraction and hemotoxylin and eosin-stained sections. Amniotic fluid samples (N = 8) were obtained from pregnant women who had cytogenetic evaluation. The content of the cysts was tested for thrombogenicity using thromboelastography. The cyst content was tested by Luminex multiplex and ELISA assays and for known prothrombotic and proinflammatory factors. Results: We identified cysts, especially those in the chorionic plate, adjacent to intervillous thrombi with apparent cyst rupture. Thromboelastography revealed a significantly shorter R time compared to whole blood control samples. Concentration of creatinine, α-fetoprotein, and surfactant D in the cyst fluid differed significantly from amniotic fluid. Cyst fluids had a significantly higher expression of all prothrombotic and some proinflammatory factors. Discussion: Our data provide the first evidence that chorionic cyst fluid is prothrombotic and different from amniotic fluid. The association of ruptured cysts with adjacent thrombi and the prothrombotic properties of cyst fluid suggest a causal relationship; however, further studies are needed.


  • Massive Perivillous Fibrinoid Deposition and Maternal Floor Infarct

    by Philip J. Katzman, Linda M. Ernst, Irene B. Scheimberg


  • Open Access

    Neonatal neuroblastoma 4s with diffuse liver metastases (Pepper syndrome) without an adrenal/extraadrenal primary identified on imaging

    by Apeksha Chaturvedi, Philip J. Katzman, Arie Franco

    We report the imaging appearances of a case of pathologically proven, neonatal neuroblastoma 4S with diffuse hepatic metastatic involvement at presentation. Patient had an abnormal appearing liver both by ultrasound and MR. There was no evidence for associated adrenal tumor by imaging. Lack of an associated adrenal mass led to initial misinterpretation of diffuse hepatic accumulation of MIBG seen with radionuclide scintigraphy. To the best our knowledge, this is the first report of metastatic neonatal 4S neuroblastoma without an adrenal (or extra-adrenal) primary identified either on pre- or post-natal imaging.